Showing results (81-90 of 99) with videos related to
Sort By:
Pageof 10
The Journal of Clinical Psychiatry|July 9, 2008
A multicenter, randomized, double-blind study of the effects of aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapineJohn W Newcomer, Joao Alberto Campos, Ronald N Marcus, et al.Frontiers in Psychiatry|July 4, 2012
Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugsJulia M Gohlke, Emily J Dhurandhar, Christoph U Correll, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 10, 2021
Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan: exploratory phase 1 results in healthy volunteersFrederico G S Toledo, William F Martin, Linda Morrow, et al.Psychiatric Services (Washington, D.C.)|April 2, 2016
Glucose Testing for Adults Receiving Medicaid and Antipsychotics: A Population-Based Prescriber Survey on Behaviors, Attitudes, and BarriersElaine H Morrato, Sarah E Brewer, Elizabeth J Campagna, et al.Journal of Child and Adolescent Psychopharmacology|April 18, 2019
Adiposity, Hepatic Triglyceride, and Carotid Intima Media Thickness During Behavioral Weight Loss Treatment in Antipsychotic-Treated Youth: A Randomized Pilot StudyGinger E Nicol, Rachel Kolko, Eric J Lenze, et al.BMC Psychiatry|December 17, 2011
Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?Marianne Ulcickas Yood, Gerald N Delorenze, Charles P Quesenberry, et al.Psychiatric Services (Washington, D.C.)|February 9, 2022
Lessons Learned From a New Reverse-Integration Model to Improve Primary Care Screening in Community Mental Health SettingsChristina Mangurian, Marilyn D Thomas, Fumi Mitsuishi, et al.Psychosomatic Medicine|January 18, 2014
Association of anxiety disorders and depression with incident heart failureLauren D Garfield, Jeffrey F Scherrer, Paul J Hauptman, et al.Schizophrenia Research|November 1, 2008
Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapineJohn W Newcomer, Jonathan M Meyer, Ross A Baker, et al.Psychoneuroendocrinology|June 19, 2003
Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotypeSuzanne Craft, Sanjay Asthana, David G Cook, et al.Pageof 10